Literature DB >> 4157296

Cholinergic enzyme systems in Parkinson's disease.

P L McGeer, E G McGeer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4157296     DOI: 10.1001/archneur.1971.00490030091011

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


× No keyword cloud information.
  8 in total

1.  A clinical trial of folic acid in Parkinson's disease.

Authors:  P L McGeer; L Zeldowicz; E G McGeer
Journal:  Can Med Assoc J       Date:  1972-01-22       Impact factor: 8.262

Review 2.  Antiparkinsonian drugs: pharmacological and therapeutic aspects.

Authors:  D B Calne; J L Reid
Journal:  Drugs       Date:  1972       Impact factor: 9.546

3.  Neurochemical asymmetry of the human cerebral hemispheres.

Authors:  V S Kononenko
Journal:  Neurosci Behav Physiol       Date:  1983 Mar-Apr

4.  Some factors influencing the neurotoxicity of intrastriatal injections of kainic acid.

Authors:  E G McGeer; P L McGeer
Journal:  Neurochem Res       Date:  1978-08       Impact factor: 3.996

5.  Regional distribution of choline acetyltransferase in the human brain: changes in Huntington's chorea.

Authors:  S M Aquilonius; S A Eckernås; A Sundwall
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-07       Impact factor: 10.154

6.  Cholinergic systems in muscle and brain in vitamin E-deficient rats.

Authors:  S C Sung; P R Sandberg; E G McGeer
Journal:  Neurochem Res       Date:  1978-12       Impact factor: 3.996

7.  The development of histochemically demonstrable cholinesterases in the rat neostriatum in vivo and in vitro.

Authors:  P Panula; L Rechardt
Journal:  Histochemistry       Date:  1979-11

8.  Synaptic morphology in the neostriatum of the rat: Possible serotonergic synapse.

Authors:  T Hattori; P L McGeer; E G McGeer
Journal:  Neurochem Res       Date:  1976-10       Impact factor: 3.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.